← Leaderboards

Bruce D Trapp

Cleveland Clinic Lerner Com-Cwru

Google Scholar ↗PubMed ↗ORCID ↗

$26,095,443

Attributed

$26,095,443

Total exposure

14

Grants

13

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.5M · FY2005–24

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$29,263,443 · 15

By mechanism

R01$12,559,446 · 6

R35$6,947,848 · 1

P50$5,412,234 · 3

R37$2,816,255 · 1

P01$1,501,257 · 1

P41$26,403 · 3

Top collaborators

No co-investigators on record.

Most similar at Cleveland Clinic Lerner Com-Cwru

Same institution · by research overlap

Cornelia C Bergmann$15,772,425

Others in their field

Top investigators on “Multiple Sclerosis”

David A. Hafler · Brigham And Women'S Hospital$33,720,341
Vijay K Kuchroo · Brigham And Women'S Hospital$32,935,587
Stephen L Hauser · University Of California San Francisco$32,469,388
Katerina Akassoglou · University Of California San Diego$24,525,425
Abdolmohamad Rostami · Thomas Jefferson University$23,969,638
Stephen D Miller · Northwestern University$23,969,272

Research focus

Multiple SclerosisDemyelinationsBrainAxonAffectMolecularNeurologicDisabilityOligodendrogliaMyelinationNeuronsPathologyMyelinInflammatoryDesignNeuraxisWhite MatterAutopsyLesionPlayMediatingProteinsBaseTherapeutic Target

Grant awards (71)

Pathogenesis of Neurological Disability in Primary Diseases of Myelin$845,598

R35 · FY2024 · NS · contact PI

Pathogenesis of Neurological Disability in Primary Diseases of Myelin$871,750

R35 · FY2023 · NS · contact PI

Pathogenesis of Neurological Disability in Primary Diseases of Myelin$871,750

R35 · FY2022 · NS · contact PI

Pathogenesis of Neurological Disability in Primary Diseases of Myelin$871,750

R35 · FY2021 · NS · contact PI

Pathogenesis of Neurological Disability in Primary Diseases of Myelin$871,750

R35 · FY2020 · NS · contact PI

Pathogenesis of Neurological Disability in Primary Diseases of Myelin$871,750

R35 · FY2019 · NS · contact PI

Pathogenesis of Neurological Disability in Primary Diseases of Myelin$871,750

R35 · FY2018 · NS · contact PI

Pathogenesis of Neurological Disability in Primary Diseases of Myelin$871,750

R35 · FY2017 · NS · contact PI

New Models For Astrocyte Function in Genetic Mouse Models of Autism Spectrum Diso$396,250

R01 · FY2017 · MH · contact PI

New Models For Astrocyte Function in Genetic Mouse Models of Autism Spectrum Diso$396,250

R01 · FY2016 · MH · contact PI

Pathogenesis of Tissue Destruction in Multiple Sclerosis$144,466

R01 · FY2016 · NS · contact PI

Hippocampal Demyelination and Cognitive Dysfunction$144,466

R01 · FY2016 · NS · contact PI

New Models For Astrocyte Function in Genetic Mouse Models of Autism Spectrum Diso$396,250

R01 · FY2015 · MH · contact PI

Pathogenesis of Tissue Destruction in Multiple Sclerosis$346,719

R01 · FY2015 · NS · contact PI

Hippocampal Demyelination and Cognitive Dysfunction$346,719

R01 · FY2015 · NS · contact PI

Tissue injury and inflammation in MS (P50)$1,060,614

P50 · FY2014 · NS · contact PI

Molecular mechanisms of Schwann cell myelination$412,560

R01 · FY2014 · NS · contact PI

New Models For Astrocyte Function in Genetic Mouse Models of Autism Spectrum Diso$396,250

R01 · FY2014 · MH · contact PI

Hippocampal Demyelination and Cognitive Dysfunction$343,251

R01 · FY2014 · NS · contact PI

Cellular and Molecular Mechanisms of Cortical Remyelination in MS Patients$316,022

P50 · FY2014 · NS · contact PI

Tissue injury and inflammation in MS (P50)$1,035,325

P50 · FY2013 · NS · contact PI

Molecular mechanisms of Schwann cell myelination$404,104

R01 · FY2013 · NS · contact PI

Astrocyte Function in Genetic Mouse Models of Autism Spectrum Disorders$394,063

R01 · FY2013 · MH · contact PI

Cellular and Molecular Mechanisms of Cortical Remyelination in MS Patients$368,852

P50 · FY2013 · NS · contact PI

Hippocampal Demyelination and Cognitive Dysfunction$346,719

R01 · FY2013 · NS · contact PI

Tissue injury and inflammation in MS (P50)$1,072,061

P50 · FY2012 · NS · contact PI

Molecular mechanisms of Schwann cell myelination$420,835

R01 · FY2012 · NS · contact PI

Cellular and Molecular Mechanisms of Cortical Remyelination in MS Patients$324,897

P50 · FY2012 · NS · contact PI

Molecular mechanisms of Schwann cell myelination$422,949

R01 · FY2011 · NS · contact PI

Pathogenesis in Demyelination of MS Brains$384,650

R01 · FY2011 · NS · contact PI

Cellular and Molecular Mechanisms of Cortical Remyelination in MS Patients$324,893

P50 · FY2011 · NS · contact PI

Molecular mechanisms of Schwann cell myelination$427,219

R01 · FY2010 · NS · contact PI

Pathogenesis in Demyelination of MS Brains$388,575

R01 · FY2010 · NS · contact PI

Cellular Mechanisms for Oligodendrocyte Myelination$334,168

R01 · FY2010 · NS · contact PI

Cellular and Molecular Mechanisms of Cortical Remyelination in MS Patients$318,115

P50 · FY2010 · NS · contact PI

Pathogenesis in Demyelination of MS Brains$392,500

R01 · FY2009 · NS · contact PI

Cellular Mechanisms for Oligodendrocyte Myelination$337,544

R01 · FY2009 · NS · contact PI

Axonal Pathology in Multiple Sclerosis$301,918

P50 · FY2009 · NS · contact PI

Molecular Mechanisms of Schwann Cell Myelination$426,080

R37 · FY2008 · NS · contact PI

Pathogenesis in Demyelination of MS Brains$392,500

R01 · FY2008 · NS · contact PI

Cellular Mechanisms for Oligodendrocyte Myelination$337,544

R01 · FY2008 · NS · contact PI

Axonal Pathology in Multiple Sclerosis$289,537

P50 · FY2008 · NS · contact PI

Molecular Mechanisms of Schwann Cell Myelination$426,679

R37 · FY2007 · NS · contact PI

Cellular Mechanisms for Oligodendrocyte Myelination$337,544

R01 · FY2007 · NS · contact PI

Axonal Pathology in Multiple Sclerosis$291,810

P01 · FY2007 · NS · contact PI

MOLECULAR MECHANISM OF SCHWANN CELL MYELINATION$5,427

P41 · FY2007 · RR · contact PI

Molecular Mechanisms of Schwann Cell Myelination$427,218

R37 · FY2006 · NS · contact PI

Cellular Mechanisms for Oligodendrocyte Myelination$347,625

R01 · FY2006 · NS · contact PI

Axonal Pathology in Multiple Sclerosis$277,950

P01 · FY2006 · NS · contact PI

MOLECULAR MECHANISM OF SCHWANN CELL MYELINATION$10,172

P41 · FY2006 · RR · contact PI

Molecular Mechanisms of Schwann Cell Myelination$382,111

R37 · FY2005 · NS

Pathogenesis of Demyelination in MS Brains$327,038

R01 · FY2005 · NS

Axonal Pathology in Multiple Sclerosis$291,144

P01 · FY2005 · NS

MOLECULAR MECHANISM OF SCHWANN CELL MYELINATION$10,804

P41 · FY2005 · RR

Molecular Mechanisms of Schwann Cell Myelination$406,560

R37 · FY2004 · NS

CELLULAR MECHANISMS OF OLIGODENDROCYTE MYELINATION$344,250

R01 · FY2004 · NS

Pathogenesis of Demyelination in MS Brains$327,038

R01 · FY2004 · NS

Molecular Mechanisms of Schwann Cell Myelination$396,051

R37 · FY2003 · NS

CELLULAR MECHANISMS OF OLIGODENDROCYTE MYELINATION$344,250

R01 · FY2003 · NS

Pathogenesis of Demyelination in MS Brains$316,350

R01 · FY2003 · NS

Molecular Mechanisms of Schwann Cell Myelination$351,556

R37 · FY2002 · NS

CELLULAR MECHANISMS OF OLIGODENDROCYTE MYELINATION$333,000

R01 · FY2002 · NS

Pathogenesis of Demyelination in MS Brains$316,350

R01 · FY2002 · NS

Axonal pathology during the course of multiple sclerosis$213,451

P01 · FY2002 · NS

CELLULAR MECHANISMS OF OLIGODENDROCYTE MYELINATION$333,000

R01 · FY2001 · NS

Axonal pathology during the course of multiple sclerosis$213,451

P01 · FY2001 · NS

MOLECULAR MECHANISMS OF SCHWANN CELL MYELINATION$211,037

R01 · FY2001 · NS

CELLULAR MECHANISMS OF OLIGODENDROCYTE MYELINATION$333,000

R01 · FY2000 · NS

Axonal pathology during the course of multiple sclerosis$213,451

P01 · FY2000 · NS

MOLECULAR MECHANISMS OF SCHWANN CELL MYELINATION$210,197

R01 · FY2000 · NS

PATHOGENESIS OF DEMYELINATION IN MS BRAINS$172,216

R01 · FY2000 · NS